α ‐Conopeptide From Conus planorbis Inhibits Glioblastoma Stem Cells and Angiogenesis via Sonic Hedgehog and ADAMDEC1–FGF2–FGFR1 Loop Signaling Pathway
Chemistry & Biodiversity · 2026
DOI: 10.1002/cbdv.202502752 ↗Kurz gefasst
Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2026. Verfasst von Sandhanam Kuppusamy und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur, Chengalpattu, India. Hauptthemen laut MEDLINE: Glioblastoma, Conus Snail, Antineoplastic Agents, Neovascularization, Pathologic. Die Arbeit nennt 29 Literaturangaben.
Abstract (Originalsprache)
Glioblastoma multiforme (GBM) is a highly aggressive primary brain tumor with limited effective treatments. This study explores the anti‐GBM potential of an α ‐conopeptide isolated from the venom of Conus planorbis , a marine cone snail from Rameswaram, India. Peptide extraction and BCA assay quantified an average concentration of 473.34 ± 70.07 µg/mL. Structural analysis via 1 H nuclear magnetic resonance (NMR) revealed a stable tertiary structure with aromatic, aliphatic, sulfur‐containing, and basic amino acids, stabilized by hydrogen bonds and disulfide bridges. Molecular docking showed strong interactions between the α ‐conopeptide and GBM‐related proteins PTCH1, FGFR1, and fibroblast growth factor 2 (FGF2), suggesting inhibition of sonic hedgehog (SHH) and ADAM‐like Decysin 1 (ADAMDEC1)–FGF2–FGFR1 loop signaling pathway. Molecular dynamics simulations confirmed stable binding with FGFR1. In vitro assays using U87 GBM cells demonstrated that the α ‐conopeptide had greater cytotoxicity (IC 50 ≈ 250 µg/mL) than temozolomide (IC 50 ≈ 320 µg/mL). Additional chorioallantoic membrane (CAM) and brine shrimp lethality tests supported its potent bioactivity, with a lower LD 50 (50.24 µg/mL) compared to temozolomide (125.82 µg/mL). These findings indicate that the α ‐conopeptide from C. planorbis possesses multi‐target anticancer activity targeting via SHH and FGFR1 loop signaling pathway, structural stability, and superior cytotoxic potency against GBM, highlighting its potential as a novel marine‐derived therapeutic agent.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, SRM College of Pharmacy, SRM Institute of Science and Technology, Kattankulathur, Chengalpattu, India.
ORCID-Profile: Sandhanam Kuppusamy, Sumithra Mohan
Zitieren
APA
Kuppusamy, S., & Mohan, S. (2026). α ‐Conopeptide From Conus planorbis Inhibits Glioblastoma Stem Cells and Angiogenesis via Sonic Hedgehog and ADAMDEC1–FGF2–FGFR1 Loop Signaling Pathway. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202502752
Vancouver
Kuppusamy S, Mohan S. α ‐Conopeptide From Conus planorbis Inhibits Glioblastoma Stem Cells and Angiogenesis via Sonic Hedgehog and ADAMDEC1–FGF2–FGFR1 Loop Signaling Pathway. Chemistry & Biodiversity. 2026. doi:10.1002/cbdv.202502752
BibTeX
@article{Kuppusamy2026,
author = {Kuppusamy, Sandhanam and Mohan, Sumithra},
title = {α ‐Conopeptide From Conus planorbis Inhibits Glioblastoma Stem Cells and Angiogenesis via Sonic Hedgehog and ADAMDEC1–FGF2–FGFR1 Loop Signaling Pathway},
journal = {Chemistry & Biodiversity},
year = {2026},
doi = {10.1002/cbdv.202502752}
}
EUVIMED